Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

2011137 citationsJournal Articlegold Open Access

Authors

Mehdi Javanbakht · Iran University of Medical Sciences

Hamid Reza Baradaran · Tehran University of Medical Sciences

Atefeh Mashayekhi · Tehran University of Medical Sciences

Ali Akbar Haghdoost · Kerman University of Medical Sciences

Mohammad E. Khamseh · Tehran University of Medical Sciences

Erfan Kharazmi · Shiraz University of Medical Sciences

Aboozar Sadeghi

Abstract

T2DM is a costly disease in the Iran healthcare system and consume more than 8.69% of total health expenditure. In addition to these quantified costs, T2DM imposes high intangible costs on society in terms of reduced quality of life. Identification of effective new strategies for the control of diabetes and its complications is a public health priority.

Topics & Keywords

Chronic Disease Management Strategies Diabetes Management and Education Diabetes, Cardiovascular Risks, and Lipoproteins

Publication Details

Published in: PLoS ONE

Volume 6, Issue 10, pp. e26864-e26864

DOI: 10.1371/journal.pone.0026864

Field-Weighted Citation Impact: 4.50

Command Palette

Cost-of-Illness Analysis of Type 2 Diabetes Mellitus in Iran

Authors

Abstract

Topics & Keywords

Publication Details